Papers and Presentations
How to use Search
You can use search for sourcing a variety of content on the CASSS website. CASSS makes available any content with author approval.
Refine Results
Filter By Content Type
Filter By Resource Type
Filter By Event Types
- WCBP (97)
- AT Europe (94)
- Cell & Gene Therapy Products (86)
- Higher Order Structure (85)
- CMC Strategy Forum (78)
- CE Pharm (57)
- Bioassays (53)
- Mass Spectrometry (50)
- CMC Strategy Forum Europe (48)
- CMC Strategy Forum North America Winter (40)
- CMC Strategy Forum Japan (33)
- CMC Strategy Forum North America Summer (24)
- CMC Strategy Forum North America Fall (14)
- CMC Strategy Forum China (14)
- CMC Strategy Forum Latin America (9)
- Biophysics Working Group (8)
- NorCal Regional Forum (6)
- Midwest Regional Forum (2)
- Netherlands Area Biotech Discussion Group (1)
- DC Area Scientific Discussion Group (1)
Filter By Tags
-
What Attributes Have Not Been Explored Using CE Methodologies?
![System.Collections.Generic.List`1[System.String] Thumbnail](https://www.casss.org/images/default-source/ce-pharm/ce2022_120x120_landing.jpg?sfvrsn=e1d1fa99_3)
Roundtable 11 Notes: CE Pharm 2019 -
Troubleshooting Complex Separations
Roundtable 10 Notes: CE Pharm 2019
-
The Good, The Bad and The Ugly for Charge Heterogeneity: Which Electrophoretic Method to Pick and When?
Roundtable 9 Notes: CE Pharm 2019
-
Specification Setting for CE Methods
Roundtable 8 Notes: CE Pharm 2019
-
Peak Characterization of CE-based Size and Charge Heterogeneity Methods?
Roundtable 7 Notes: CE Pharm 2019
-
Identifying New Attributes of Drugs Using Capillary Electrophoresis
Roundtable 6 Notes: CE Pharm 2019
-
Future of CE with MAM Used in QC for Lot Release/Stability?
Roundtable 5 Notes: CE Pharm 2019
-
CE's Role in Real Time Release Testing/PAT
Roundtable 4 Notes: CE Pharm 2019
-
CE Usage for Process and Product Characterization
Roundtable 3 Notes: CE Pharm 2019
-
CE in Forced Degradation
Roundtable 2 Notes: CE Pharm 2019
-
Advantages and Challenges for Implementing CE-MS and Other New Technologies
Roundtable 1 Notes: CE Pharm 2019
-
Recent Advances of Capillary Electrokinetic Separation Technologies and their Applications in Pharmaceutical and Biochemical Analyses
Speaker Presentation Yan Chao, Shanghai Jiao Tong University, 2019
-
Micelle-Tagging Electrophoresis: Rapid, Gel-Free Detection and Separation of DNA
Speaker Presentation Yan Bruce, Carnegie Mellon University, 2019
-
CE-SDS vs SDS-PAGE: A Comparative Study of Molecular Mass Determination Methods
Speaker Presentation Wiesner Rebecca, University of Braunschweig, 2019
-
Protein Analysis by CE: Successes and Challenges
Speaker Presentation Watzig Hermann, University of Braunschweig, 2019
-
No Observations on My Watch - A Practical Guide to Regulatory Agency Inspections of Analytical Laboratories
Speaker Presentation Kennett Sarah, Genentech, a Member of the Roche Group, 2019
-
Nucleic Acid Therapy Purity Methods by Capillary Gel Electrophoresis
Speaker Presentation Jensen Jordan, Covance, 2019
-
Implementation of Empower 3 for CE Instrument Control, Data Acquisition, and Reporting in a Global Multi-Product QC Environment
Speaker Presentation Binder Edith, Boehringer Ingelheim, 2019
-
CMC North America 2022 Scientific Program
![System.Collections.Generic.List`1[System.String] Thumbnail](http://www.casss.org/images/default-source/cmc-north-america/cmcs2022_120x120_landing.jpg?sfvrsn=237e8e2a_3)
Scientific Program: CMC North America 2022 -
Svar Life Science - Vendor/Technical Presentation
![System.Collections.Generic.List`1[System.String] Thumbnail](https://www.casss.org/images/default-source/bioassays/bioa2022_120x120_landing_030922.jpg?sfvrsn=7d4e2b1d_3)
Speaker Presentation Schwenkert Michael Svar Vendor 2022
View On Demand Content
To view the content, visit https://casss.digitellinc.com, login to your account, and select the meeting from the list of past events. Visit the On Demand Presentations and Speaker Slides tab to view available content.
For 2021 meetings, content will be available for one year after the program. For 2022 and beyond, content will be available for three months.